Cabatcha, Erik .

HRN: 25-35-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2024
CEFTRIAXONE 1G (VIAL)
06/30/2024
07/07/2024
IV
2g
Od
CAP MR
Waiting Final Action 
06/30/2024
AZITHROMYCIN 500MG TABLET (TAB)
06/30/2024
07/05/2024
PO
500
OD
CAP
Waiting Final Action 
07/01/2024
CEFTRIAXONE 1G (VIAL)
07/01/2024
07/07/2024
IV
2gm
Bid
Cns Infection
Waiting Final Action 
07/03/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/03/2024
07/09/2024
IV
2.25gm
Q6
Cap HR
Waiting Final Action 
07/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/04/2024
07/11/2024
IV
2.25g
Q8
CAP HR (elevated Crea)
Waiting Final Action 
07/04/2024
CEFTRIAXONE 1G (VIAL)
07/04/2024
07/11/2024
IV
2g
Q12
T/c Typhoid Encephalopathy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: